Cheng Du Sheng Nuo Biotec Co. Ltd. A Net Assets

Latest as of September 2025: CN¥1.03 Billion CNY ≈ $151.00 Million USD

Cheng Du Sheng Nuo Biotec Co. Ltd. A net assets. Based on the latest financial reports, Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) has net assets worth CN¥1.03 Billion CNY (≈ $151.00 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.91 Billion ≈ $279.37 Million USD) and total liabilities (CN¥877.24 Million ≈ $128.37 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) equity growth momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥1.03 Billion
% of Total Assets	54.05%
Annual Growth Rate	21.0%
5-Year Change	109.87%
10-Year Change	N/A
Growth Volatility	25.02

Net Assets of Cheng Du Sheng Nuo Biotec Co. Ltd. A (2017–2024)

Net assets of Cheng Du Sheng Nuo Biotec Co. Ltd. A from 2017 to 2024. This chart illustrates how Cheng Du Sheng Nuo Biotec Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. See Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) net asset quality to measure how much of total assets are equity-financed.

Annual Net Assets for Cheng Du Sheng Nuo Biotec Co. Ltd. A (2017–2024)

The table below shows the annual net assets of Cheng Du Sheng Nuo Biotec Co. Ltd. A from 2017 to 2024. For live market cap and overall valuation, see Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) total market value.

Year	Net Assets	Change
2024-12-31	CN¥918.32 Million ≈ $134.38 Million	+4.34%
2023-12-31	CN¥880.10 Million ≈ $128.79 Million	+6.45%
2022-12-31	CN¥826.74 Million ≈ $120.98 Million	+5.30%
2021-12-31	CN¥785.14 Million ≈ $114.89 Million	+79.43%
2020-12-31	CN¥437.57 Million ≈ $64.03 Million	+16.23%
2019-12-31	CN¥376.46 Million ≈ $55.09 Million	+15.00%
2018-12-31	CN¥327.35 Million ≈ $47.90 Million	+35.42%
2017-12-31	CN¥241.74 Million ≈ $35.37 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Cheng Du Sheng Nuo Biotec Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 319.5% over the analyzed period, indicating profitable operations and earnings retention.

Cheng Du Sheng Nuo Biotec Co. Ltd. A Net Assets Breakdown (December 2024)

Cheng Du Sheng Nuo Biotec Co. Ltd. A net assets breakdown by equity component as of December 2024.

Component	Amount	Percentage
Retained Earnings	CN¥397.63 Million	43.30%
Common Stock	CN¥112.42 Million	12.24%
Other Components	CN¥408.29 Million	44.46%
Total Equity	CN¥918.34 Million	100.00%

Cheng Du Sheng Nuo Biotec Co. Ltd. A Competitors by Market Cap

The table below lists competitors of Cheng Du Sheng Nuo Biotec Co. Ltd. A ranked by their market capitalization.

Company	Market Cap
Guggenheim Taxable Municipal Managed Duration Trust NYSE:GBAB	$345.69 Million
Beijing Hanbang Technology Corp SHE:300449	$345.71 Million
RFG Holdings Ltd JSE:RFG	$345.79 Million
Kambi Group Plc F:7KB	$345.83 Million
Atea Pharmaceuticals Inc NASDAQ:AVIR	$345.68 Million
Qumei Furniture Group Co Ltd SHG:603818	$345.59 Million
SPCG Public Company Limited BK:SPCG	$345.53 Million
Zoneco Group Co Ltd SHE:002069	$345.47 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cheng Du Sheng Nuo Biotec Co. Ltd. A's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 879,928,271 to 918,343,435, a change of 38,415,164 (4.4%).
Net income of 50,023,708 contributed positively to equity growth.
Dividend payments of 34,166,640 reduced retained earnings.
Other factors increased equity by 22,558,096.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥50.02 Million	+5.45%
Dividends Paid	CN¥34.17 Million	-3.72%
Other Changes	CN¥22.56 Million	+2.46%
Total Change	CN¥-	4.37%

Book Value vs Market Value Analysis

This analysis compares Cheng Du Sheng Nuo Biotec Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.86x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 5.08x to 1.86x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	CN¥2.95	CN¥15.01	x
2018-12-31	CN¥3.99	CN¥15.01	x
2019-12-31	CN¥3.36	CN¥15.01	x
2020-12-31	CN¥7.13	CN¥15.01	x
2021-12-31	CN¥9.89	CN¥15.01	x
2022-12-31	CN¥7.38	CN¥15.01	x
2023-12-31	CN¥7.76	CN¥15.01	x
2024-12-31	CN¥8.08	CN¥15.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cheng Du Sheng Nuo Biotec Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.45%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 10.97%
• Asset Turnover: 0.28x
• Equity Multiplier: 1.79x
Recent ROE (5.45%) is below the historical average (9.84%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2017	14.02%	17.43%	0.56x	1.44x	CN¥9.73 Million
2018	9.12%	10.74%	0.58x	1.46x	CN¥-2.87 Million
2019	12.79%	14.73%	0.63x	1.38x	CN¥10.49 Million
2020	13.71%	15.84%	0.64x	1.36x	CN¥16.24 Million
2021	7.80%	15.85%	0.40x	1.22x	CN¥-17.26 Million
2022	7.80%	16.30%	0.36x	1.34x	CN¥-18.19 Million
2023	7.99%	16.17%	0.33x	1.50x	CN¥-17.66 Million
2024	5.45%	10.97%	0.28x	1.79x	CN¥-41.81 Million

Industry Comparison

This section compares Cheng Du Sheng Nuo Biotec Co. Ltd. A's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $1,554,577,785
Average return on equity (ROE) among peers: 7.31%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117)	CN¥1.03 Billion	14.02%	0.85x	$345.69 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$1.45 Billion	1.52%	1.57x	$485.12 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$576.00 Million	3.15%	0.28x	$363.11 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$1.12 Billion	13.25%	0.26x	$4.79 Billion
Livzon Pharmaceutical Group Inc (000513)	$623.47 Million	16.22%	0.40x	$2.70 Billion
Wedge Industrial Co Ltd (000534)	$654.70 Million	1.92%	0.87x	$1.28 Billion
Yunnan Baiyao Group Co Ltd (000538)	$184.00 Million	12.94%	0.09x	$14.40 Billion
Hainan Haiyao Co Ltd (000566)	$2.20 Billion	-4.84%	2.35x	$770.77 Million
Tus Pharmaceutical Group Co Ltd (000590)	$728.20 Million	3.47%	0.58x	$275.43 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$5.67 Billion	4.59%	1.27x	$925.00 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$2.34 Billion	20.86%	0.40x	$3.01 Billion

About Cheng Du Sheng Nuo Biotec Co. Ltd. A

SHG:688117 China Drug Manufacturers - Specialty & Generic

Market Cap

$345.69 Million

CN¥2.36 Billion CNY

Market Cap Rank

#13813 Global

#4091 in China

Share Price

CN¥15.01

Change (1 day)

-2.91%

52-Week Range

CN¥14.14 - CN¥46.10

All Time High

CN¥48.78